Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Im-patient who wrote (256)	2/1/1997 6:04:00 PM
From: Kumar Nathan	of 6136

I am wondering whether the european distribution will welcome group will be much more fruitful then "roche".Roche is also marketing another PI drug whereas Welcome Group is distributing AZT. Viracept is a PI and mainly a cocktail drug. If Welcome markets this drug, it will more effective than roche marketing it. Just my $.02 Kumar.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next